Bioventus Inc. (BVS)
NASDAQ: BVS · IEX Real-Time Price · USD
5.20
+0.04 (0.78%)
At close: Mar 28, 2024, 4:00 PM
5.17
-0.03 (-0.58%)
After-hours: Mar 28, 2024, 4:23 PM EDT

Bioventus Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
36.9630.1949.2186.8464.5242.77
Cash & Cash Equivalents
36.9630.1949.2186.8464.5242.77
Cash Growth
22.45%-38.66%-43.33%34.59%50.84%-
Receivables
122.79136.3124.9688.2885.1372.57
Inventory
91.3384.7761.6929.1227.3327.4
Other Current Assets
16.9121.3327.247.556.065.62
Total Current Assets
268272.58263.1211.79183.03148.35
Property, Plant & Equipment
49.9644.1540.1721.8419.764.76
Long-Term Investments
3.142.6279.2919.383.312.78
Goodwill and Intangibles
489.81647.31842.82241.45266.31286.83
Other Long-Term Assets
0405.990.48000
Total Long-Term Assets
542.911,100962.76282.67289.37294.37
Total Assets
810.911,3731,226494.47472.41442.72
Accounts Payable
23.0436.716.924.426.448.21
Current Debt
27.8533.0618.0415105.25
Other Current Liabilities
124.61234.26145.91103.1772.5851.97
Total Current Liabilities
175.5304.02180.86122.5989.0265.43
Long-Term Debt
367385.01339.64173.38187.97189.58
Other Long-Term Liabilities
47.3271.4171.5754.3449.8142.45
Total Long-Term Liabilities
414.3656.41511.21227.72237.78232.03
Total Liabilities
589.79960.43692.07350.31326.79297.46
Total Debt
394.85418.07357.68188.38197.97194.83
Debt Growth
-5.55%16.88%89.87%-4.84%1.61%-
Retained Earnings
-321.54-165.31-6.60-141.7-139.82
Comprehensive Income
0.79-0.110.180-0.47-0.07
Shareholders' Equity
173.59325.24458.92144.16142.98145.27
Net Cash / Debt
-357.88-387.88-308.47-101.54-133.45-152.05
Net Cash Per Share
-5.71-6.32-6.78-20.72-27.23-31.03
Working Capital
92.5-31.4482.2489.2194.0282.93
Book Value Per Share
2.775.3010.0929.4229.1829.65
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).